The Neuraminidase Inhibitor Oseltamivir Is Effective Against A/Anhui/1/2013 (H7N9) Influenza Virus in a Mouse Model of Acute Respiratory Distress Syndrome-Reference-Cited by-同舟云学术

The Neuraminidase Inhibitor Oseltamivir Is Effective Against A/Anhui/1/2013 (H7N9) Influenza Virus in a Mouse Model of Acute Respiratory Distress Syndrome

Published:2013-10-16 Issue:9 Volume:209 Page:1343-1353
ISSN:0022-1899
Container-title:Journal of Infectious Diseases
language:en
Short-container-title:Journal of Infectious Diseases

Author:

Baranovich T.,Burnham A. J.,Marathe B. M.,Armstrong J.,Guan Y.,Shu Y.,Peiris J. M. S.,Webby R. J.,Webster R. G.,Govorkova E. A.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Immunology and Allergy

Link

http://academic.oup.com/jid/article-pdf/209/9/1343/2629027/jit554.pdf

Reference32 articles.

1. Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus

2. Avian influenza A virus (H7N7) associated with human conjunctivitis and a fatal case of acute respiratory distress syndrome

3. Major Challenges in Providing an Effective and Timely Pandemic Vaccine for Influenza A(H7N9)

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flavonoid substituted polysaccharides from Tamarix chinensis Lour. alleviate H1N1-induced acute lung injury via inhibiting complement system;Journal of Ethnopharmacology;2024-03

2. FDA-approved Abl/EGFR/PDGFR kinase inhibitors show potent efficacy against pandemic and seasonal influenza A virus infections of human lung explants;iScience;2023-04

3. Ex Vivo Validation of Six FDA-Approved Non-Receptor Tyrosine Kinase Inhibitors (NRTKIs) as Antivirals to Pandemic and Seasonal Influenza A Viruses;2022-01-20

4. Substitution of I222L-E119V in neuraminidase from highly pathogenic avian influenza H7N9 virus exhibited synergistic resistance effect to oseltamivir in mice;Scientific Reports;2021-08-11

5. A77 1726, the active metabolite of the anti‐rheumatoid arthritis drug leflunomide, inhibits influenza A virus replication in vitro and in vivo by inhibiting the activity of Janus kinases;The FASEB Journal;2020-06-29